Routes of Administration

Oral

• SupraVail® Porous Nano Matrix: highly porous nanoparticles
• SupraVail® Membrane Lipid Matrix: phospholipid-based full solubilization
• SupraVail® Solid Lipophilic Matrix: lipophilic coprecipitates
• Phares Conventional Formulation Services: alternative and reference formulations based on standard technologies

Parenteral

• SupraVail® Instant Solubilization System: intravenous delivery system for poorly soluble actives
• SupraVail® Membrane Lipid Matrix: phospholipid-based full solubilization
• Phares Conventional Formulation Services: alternative and reference formulations based on standard technologies

Topical

• SupraVail® Membrane Lipid Matrix: phospholipid-based full solubilization
• SupraVail® Porous Nano Matrix: highly porous nanoparticles
• Phares Conventional Formulation Services: alternative and reference formulations based on standard technologies

BioPharm America
Atlanta, Georgia
September 9-10, 2008

AAPS
Atlanta, Georgia
November 16-20, 2008

BIO-Europe
Mannheim/Heidelberg, Germany
November 17-19, 2008

BIO-Europe Spring
Milan, Italy
March 16-18, 2009